Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma
This study has suspended participant recruitment.
(Budgetary issues)
Sponsor:
Hoosier Oncology Group
Collaborator:
Novartis Pharmaceuticals
Information provided by:
Hoosier Oncology Group
ClinicalTrials.gov Identifier:
NCT01071928
First received: February 18, 2010
Last updated: August 20, 2010
Last verified: August 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |